Current evidence suggests that FMRP and the brain-derived neurotrophic factor (BDNF) may regulate each other and alterations in BDNF expression modify the phenotype of FXS and ASD (Nishimura et al., 2007; Castrén and Castrén, 2014). This evidence concerns the gene BDNF and fragile X syndrome.